Transgenic expression of CECR1 adenosine deaminase in mice results in abnormal development of heart and kidney

Ali M Riazi1, Glen Van Arsdell, Manuel Buchwald

  • 1Division of Cardiovascular Surgery, Hospital for Sick Children, Toronto, ON, Canada. ali.riazi@sickkids.ca

Transgenic Research
|September 9, 2005
PubMed

Insights

Cat eye syndrome, a rare genetic disorder, was modeled in mice by overexpressing the CECR1 gene. This research revealed significant embryonic lethality and heart, kidney, and eye abnormalities in the affected mice.

Area of Science:

  • Genetics
  • Developmental Biology
  • Animal Models

Background:

  • Cat eye syndrome is a rare genetic disorder characterized by duplication of chromosome 22q11.
  • Patients exhibit distinct heart, kidney, and eye abnormalities.

Purpose of the Study:

  • To develop a mouse model for Cat eye syndrome by expressing the CECR1 adenosine deaminase gene.
  • To investigate the effects of CECR1 duplication on embryonic development and organogenesis.

Main Methods:

  • Generated transgenic mice with CECR1 expression under a ubiquitous (beta-actin) or heart-specific (myosin heavy chain) promoter.
  • Monitored embryonic and neonatal survival rates.
  • Assessed cardiac, renal, and ocular phenotypes in the transgenic mice.

Main Results:

  • Transgenic mice with heart-specific CECR1 expression exhibited high embryonic and neonatal lethality.
  • All examined transgenic lines displayed cardiac enlargement (cardiomegaly).
  • Abnormalities in kidney and eye development were observed in mice with ubiquitous CECR1 expression.

Conclusions:

  • Overexpression of CECR1 can recapitulate key features of Cat eye syndrome in a mouse model.
  • CECR1 plays a critical role in embryonic development, particularly in cardiac, renal, and ocular systems.
  • This mouse model provides a valuable tool for studying the pathogenesis of Cat eye syndrome and for developing therapeutic strategies.